BrightSpring Health Services, Inc. Common Stock (BTSG)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $14.17B
Last updated: Nov 17, 2026 at 11:05 AM ET
BrightSpring Health Services, Inc. Common Stock (BTSG) Financials: Revenue, Profit and Cash Flow
BrightSpring Health Services, Inc. Common Stock reported revenue of $12.91B for the fiscal year ended Dec 31, 2025, up 28.2% from the year before. That year, net income was $189.11M with a net margin of 1.5%, operating cash flow was $490.17M and free cash flow was $394.69M. The quarter ended Sep 30, 2026 had revenue of $4.21B and net income of $100.30M.
Revenue and Margins
The operating margin was 2.3% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $2.54B, a compound annual rate of 26.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $12.91B | +28.2% | 11.8% | 2.3% | 1.5% |
| Dec 2024 | $10.07B | +31.0% | 12.6% | 1.1% | -0.2% |
| Dec 2023 | $7.69B | -0.4% | 14.8% | 0.8% | -2.0% |
| Dec 2022 | $7.72B | +15.3% | 17.5% | 2.4% | -0.7% |
| Dec 2021 | $6.70B | +20.0% | 18.6% | 3.5% | 0.7% |
| Dec 2020 | $5.58B | +23.3% | 18.8% | 3.0% | 0.4% |
| Dec 2019 | $4.53B | +78.4% | 18.4% | 1.4% | -1.6% |
| Dec 2018 | $2.54B | N/A | 14.8% | 3.0% | -0.3% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 81.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.91B | $10.07B | $7.69B | $7.72B | $6.70B | $5.58B | $4.53B | $2.54B |
| Cost of revenue | $11.39B | $8.81B | $6.55B | $6.37B | $5.45B | $4.53B | $3.69B | $2.16B |
| Gross profit | $1.52B | $1.27B | $1.14B | $1.35B | $1.25B | $1.05B | $833.91M | $375.91M |
| Operating income | $295.25M | $107.95M | $58.13M | $187.83M | $234.18M | $165.19M | $63.31M | $74.85M |
| Net income | $189.11M | -$20.52M | -$156.84M | -$54.22M | $49.80M | $20.81M | -$72.38M | -$7.62M |
| EBITDA | $470.77M | $324.54M | $281.38M | $412.24M | $433.34M | $346.69M | $218.18M | $156.02M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.21B | $3.87B | $3.61B | $3.55B | $3.33B | $3.15B | $2.88B | $2.75B | $2.60B | $2.44B | $2.29B | $1.24B |
| Gross profit | $518.55M | $492.75M | $482.22M | $412.55M | $392.01M | $374.85M | $338.37M | $338.67M | $323.09M | $312.18M | $292.49M | $73.92M |
| Operating income | $160.48M | $130.39M | $121.45M | $108.11M | $87.84M | $48.56M | $50.74M | $55.54M | $29.10M | $38.65M | -$15.34M | -$20.79M |
| Net income | $100.30M | $84.21M | $148.61M | $77.32M | $55.24M | $27.54M | $29.01M | $15.40M | -$8.98M | $19.44M | -$46.38M | -$7.20M |
Balance Sheet
As of Dec 2025, total debt of $2.51B exceeded cash and equivalents by $2.42B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $6.41B | $5.93B | $5.53B | $5.44B | $5.51B | $4.54B | $3.82B | N/A |
| Current assets | $2.89B | $1.89B | $1.46B | $1.34B | $1.18B | $1.29B | $870.68M | N/A |
| Cash and equivalents | $88.37M | $60.95M | $13.07M | $13.63M | $46.73M | $262.00M | $18.30M | N/A |
| Total liabilities | $4.53B | $4.27B | $4.92B | $4.66B | $4.71B | $3.81B | $3.11B | N/A |
| Short-term debt | $52.34M | $48.73M | $32.27M | $107.86M | $125.22M | $91.01M | $89.50M | N/A |
| Long-term debt | $2.46B | $2.56B | $3.33B | $3.36B | $3.39B | $2.67B | N/A | N/A |
| Shareholder equity | $1.88B | $1.65B | $584.74M | $754.78M | $774.82M | $704.98M | $656.87M | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.27B | $5.99B | $6.21B | $6.41B | $6.05B | $5.94B | $5.85B | $5.93B | $5.79B | $5.61B | $5.66B | $5.53B |
| Total liabilities | $4.08B | $3.93B | $4.22B | $4.53B | $4.23B | $4.20B | $4.16B | $4.27B | $4.17B | $4.00B | $4.08B | $4.92B |
| Cash and equivalents | $717.84M | $550.38M | $888.80M | $88.37M | $140.34M | $70.07M | $52.34M | $61.25M | $35.97M | $25.03M | $58.04M | $13.07M |
| Shareholder equity | $2.18B | $2.05B | $1.98B | $1.88B | $1.82B | $1.74B | $1.69B | $1.65B | $1.61B | $1.60B | $1.57B | $584.74M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 80.5% of operating cash flow. Share repurchases came to 12.2% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $490.17M | $23.77M | $210.78M | -$4.65M | $270.17M | $222.64M | $110.91M | $76.45M |
| Capital expenditures | $95.48M | $80.91M | $73.53M | $70.11M | $59.27M | $51.91M | $51.22M | $33.20M |
| Free cash flow | $394.69M | -$57.14M | $137.26M | -$74.77M | $210.90M | $170.73M | $59.69M | $43.25M |
| Dividends paid | N/A | N/A | N/A | $750.00K | N/A | N/A | N/A | N/A |
| Share repurchases | $48.27M | $2.97M | $650.00K | $0 | N/A | N/A | N/A | N/A |
| Investing cash flow | -$305.08M | -$140.24M | -$134.43M | $45.36M | -$1.19B | -$452.87M | -$1.53B | -$37.34M |
| Financing cash flow | -$157.87M | $164.65M | -$76.91M | -$73.81M | $705.22M | $473.94M | $1.41B | -$32.21M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $204.32M | $43.92M | $122.94M | $231.56M | $107.94M | $49.08M | $101.60M | $90.61M | $27.25M | -$15.22M | -$78.86M | $162.40M |
| Capital expenditures | $22.09M | $29.03M | $21.54M | $37.66M | $15.76M | $24.43M | $17.63M | $15.31M | $20.04M | $23.74M | $21.82M | $16.83M |
| Free cash flow | $182.23M | $14.88M | $101.40M | $193.89M | $92.17M | $24.65M | $83.97M | $75.30M | $7.20M | -$38.97M | -$100.67M | $145.57M |
Frequently Asked Questions About BTSG
What is BrightSpring Health Services, Inc. Common Stock's annual revenue?
BrightSpring Health Services, Inc. Common Stock reported revenue of $12.91B for the fiscal year ended Dec 31, 2025.
How fast is BrightSpring Health Services, Inc. Common Stock's revenue growing?
Revenue was up 28.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 18.7%.
Is BrightSpring Health Services, Inc. Common Stock profitable?
Yes. BrightSpring Health Services, Inc. Common Stock reported net income of $189.11M for the fiscal year ended Dec 31, 2025, with a net margin of 1.5%.
How much free cash flow does BTSG generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $490.17M minus capital expenditures of $95.48M produced free cash flow of $394.69M.
How much debt does BrightSpring Health Services, Inc. Common Stock have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.46B, short-term debt of $52.34M and cash and equivalents of $88.37M.
BTSG pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors